Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Revenue Recognition Changed

Re: Opty

in response to by
posted on Jan 09, 2008 07:28PM

i am sorry but i really disagree.  the mmp, imo, is not the issue.  the mmp is generating revenue.....it is the company ptsc that is being questioned by the investor.  i have been beating the BOD drum so long that i am labeled by most as a basher.  it is the non permormance by our 5 person company that is killing the stock price.  the mmp will generate revenue....it has been for 2 years and licensed by some of the most prestigous names in the industry.

the revenues for a 5 man corp with no debt and the potential for big money down the road is there.......we cannot deny this...we have had revenue for almost 2 years now.  yet we trade down.  the finger needs to be pointed at the ones that are running this "employless" comapny.  our future lies with them.....and we still are waiting to find out where we are.....i expect a minimal press release of appeasal by JT sating we are restricted by NDAS.....

ok.....enough for tonite.....sorry for negativism....but too many repeated disappointments.....teremoto

Share
New Message
Please login to post a reply